Multi-center observational study to investigate the effect of immune checkpoint inhibitors on MSI-H/dMMR solid tumors
Not Applicable
Recruiting
- Conditions
- MSI-H/dMMR solid tumor
- Registration Number
- JPRN-UMIN000044728
- Lead Sponsor
- ational Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) patients judged to be inappropriate by a physician in charge 2) Excluded from research subjects when there is a refusal to use samples and information (opt-out) in cases where consent has not been obtained.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of clinicopathological and molecular biological features related to the efficacy of immune checkpoint inhibitors.
- Secondary Outcome Measures
Name Time Method